Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.67 - $2.85 $8,701 - $37,012
12,987 New
12,987 $9,000
Q1 2021

May 17, 2021

SELL
$12.07 - $29.9 $210,693 - $521,934
-17,456 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$13.25 - $34.58 $231,292 - $603,628
17,456 New
17,456 $505,000

Others Institutions Holding SQZ

About SQZ Biotechnologies Co


  • Ticker SQZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,248,600
  • Market Cap $1.46M
  • Description
  • SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...
More about SQZ
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.